Zobrazeno 1 - 10
of 325
pro vyhledávání: '"Kwang Kon Koh"'
Autor:
Hyun-Jin Kim, Mi-Seung Shin, Kyung-Hee Kim, Mi-Hyang Jung, Dong-Hyuk Cho, Ju-Hee Lee, Kwang Kon Koh
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 2, Pp 272-282 (2024)
Background/Aims Metabolic syndrome (MetS) raises the risk of cardiovascular disease and type 2 diabetes. An awareness of MetS is vital for early detection and proactive management, which can mitigate the risks associated with MetS. Therefore, our stu
Externí odkaz:
https://doaj.org/article/051fcf7eae13447ba52742409cb6f6e0
Autor:
Jin-Seok Kim, Seon Won Kim, Jong Seok Lee, Seung Ku Lee, Robert Abbott, Ki Yeol Lee, Hong Euy Lim, Ki-Chul Sung, Goo-Yeong Cho, Kwang Kon Koh, Sun H. Kim, Chol Shin, Seong Hwan Kim
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-9 (2021)
Abstract Background The independent role of pericardial adipose tissue (PAT) as an ectopic fat associated with cardiovascular disease (CVD) remains controversial. This study aimed to determine whether PAT is associated with left ventricular (LV) stru
Externí odkaz:
https://doaj.org/article/4e5aadaec738405c8166afc638b79af7
Autor:
Ji Hye Huh, Sung Gyun Ahn, Young In Kim, Taehwa Go, Ki-Chul Sung, Jae Hyuk Choi, Kwang Kon Koh, Jang Young Kim
Publikováno v:
Diabetes & Metabolism Journal, Vol 43, Iss 4, Pp 530-538 (2019)
BackgroundMetabolic syndrome (MetS) is a known predictor of diabetes mellitus (DM), but whether longitudinal changes in MetS status modify the risk for DM remains unclear. We investigated whether changes in MetS status over 2 years modify the 10-year
Externí odkaz:
https://doaj.org/article/ee24ca580988432abc467222bb2a2bbb
Publikováno v:
Cardiovascular Research. 118:2074-2084
Adiponectin is an adipocyte-derived cytokine known for its cardioprotective effects in preclinical studies. Early epidemiologic studies replicated these findings and drew great interest. Subsequent large-scale prospective cohorts, however, showed tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41b35b0196329eacbab1038642698fe7
https://doi.org/10.1093/cvr/cvab199
https://doi.org/10.1093/cvr/cvab199
Publikováno v:
Circulation Journal. 85:759-768
Dyslipidemia is one of the most important risk factors for cardiovascular (CV) disease. Statin therapy has dramatically improved CV outcomes and is the backbone of current lipid-lowering therapy, but despite well-controlled low-density lipoprotein ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c853d98ad748afd1633f3bc8c38f42
https://doi.org/10.1253/circj.cj-20-1037
https://doi.org/10.1253/circj.cj-20-1037
Autor:
Seong Hwan Kim, Sun H. Kim, Goo Yeong Cho, Ki Yeol Lee, Kwang Kon Koh, Robert D. Abbott, Seung Ku Lee, Jong Seok Lee, Chol Shin, Seon Won Kim, Jin Seok Kim, Hong Euy Lim, Ki Chul Sung
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-9 (2021)
Cardiovascular Diabetology
Cardiovascular Diabetology
Background The independent role of pericardial adipose tissue (PAT) as an ectopic fat associated with cardiovascular disease (CVD) remains controversial. This study aimed to determine whether PAT is associated with left ventricular (LV) structure and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f0aea312a87a5ba797936e3139c4d6c
https://doaj.org/article/4e5aadaec738405c8166afc638b79af7
https://doaj.org/article/4e5aadaec738405c8166afc638b79af7
Publikováno v:
Circulation Journal. 84:867-874
Two decades ago, it was recognized that lipoprotein(a) (Lp(a)) concentrations were elevated in patients with cardiovascular disease (CVD). However, the importance of Lp(a) was not strongly established due to a lack of both Lp(a)-lowering therapy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ab73c76603c49d609d28e8d4f70d95a
https://doi.org/10.1253/circj.cj-20-0051
https://doi.org/10.1253/circj.cj-20-0051
Autor:
Seung Hwan Han, Albert Youngwoo Jang, Min Soo Kim, Kyounghoon Lee, Mi-Seung Shin, Kwang Kon Koh
Publikováno v:
CardioMetabolic Syndrome Journal. 3:87
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b666bf20003b67021c94df2c039f67e9
https://doi.org/10.51789/cmsj.2023.3.e11
https://doi.org/10.51789/cmsj.2023.3.e11
Autor:
Jae Hyuk Choi, Tae-Hwa Go, Sung Gyun Ahn, Jang Young Kim, Ji Hye Huh, Kwang Kon Koh, Young In Kim, Ki Chul Sung
Publikováno v:
Diabetes & Metabolism Journal, Vol 43, Iss 4, Pp 530-538 (2019)
Diabetes & Metabolism Journal
Diabetes & Metabolism Journal
BACKGROUND Metabolic syndrome (MetS) is a known predictor of diabetes mellitus (DM), but whether longitudinal changes in MetS status modify the risk for DM remains unclear. We investigated whether changes in MetS status over 2 years modify the 10-yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::901138e37a714ab9523cab8bd73cc610
http://e-dmj.org/upload/pdf/dmj-43-530.pdf
http://e-dmj.org/upload/pdf/dmj-43-530.pdf
Publikováno v:
Circulation Journal. 83:504-510
Until the 2017 ACC/AHA Hypertension Guidelines were released, the target blood pressure (BP) for adults with hypertension (HTN) was 140/90 mmHg in most of the guidelines. The new 2018 ESC/ESH, Canadian, Korean, Japan, and Latin American hypertension
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad67631ac043afcc6f5c6d1a2e5f560c
https://doi.org/10.1253/circj.cj-18-1293
https://doi.org/10.1253/circj.cj-18-1293